Food and Drug Administration (FDA) unanimously recommended approval of the Companys Pre-Market Approval (PMA)...

Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week We're a pay-per-view site for premium content!

If you'd like to...

The electrocardiograph amplifies and filters these small electrical signals and graphs this signal in voltage...

The drug maker Ethex sent out sent out oversized tablets, some double the expected dosage.

The...

Food and Drug...

20 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc., (OTC Bulletin Board: DSKA - News), announced today that it has submitted its pivotal Phase 3 ATPace clinical trial protocol for review under a Special Protocol...

In preparation for an anesthetic procedure, we must know our patients well in order to be successful.

We evaluate each...

WHEELER, Jeffery, Jerome BEATCH, Gregory, N.

Title Abstract The present invention provides methods of treating and preventing arrhythmia and other diseases or disorders, using ion...

17 /PRNewswire-FirstCall/ -- Biotel Inc.

announced results for its first quarter ended September 30, 2008, with net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000.

This compares to net...

17 /PRNewswire/ -- TYRX, Inc., a leader in the development and commercialization of...

17 /PRNewswire/ -- TYRX, Inc., a leader in the development and commercialization of...

17 /PRNewswire-FirstCall/ -- Biotel Inc.

announced results for its first quarter ended September 30, 2008, with net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000.

This compares to net...

17 /PRNewswire-FirstCall/ -- Biotel Inc.

announced results for its first quarter ended September 30, 2008, with net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000.

This compares to net...

17 /PRNewswire-FirstCall/ -- Biotel Inc.

announced results for its first quarter ended September 30, 2008, with net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000.

This compares to net...

However, a team of researchers from Wake Forest University Baptist Medical Center, University...

Food and Drug...

When treatment options dwindle or are exhausted, terminally ill-patients often opt for pain management and comfort over life-extending therapies.

However, a team of researchers from , University of Rochester Medical...

23 (HealthDay News) -- Common drugs prescribed for chronic obstructive pulmonary disease (COPD) are associated with an increased risk of heart attack, stroke and other cardiovascular problems, researchers report.

These...